|
Getting your Trinity Audio player ready...
|
- INJ is rebounding after another October cycle low, now trading back near $6.
- Injective’s EVM mainnet launch strengthens long-term fundamentals.
- Historical patterns suggest momentum could build through early 2026.
Injective’s market story is gaining attention again after its EVM mainnet quietly went live last week, marking one of the project’s most important upgrades in years. As INJ begins to recover from a steep 2025 decline, traders are revisiting an old pattern that has defined every major move in its history: deep corrections followed by equally powerful rebounds.
A Familiar Cycle Re-Emerges
Injective has built a reputation for sharp swings, but its long-term structure has shown remarkable consistency. Since trading near $0.40 in 2021, the token has moved through several extreme cycles—rallying to $25, collapsing to $1.45, then exploding to a new high near $53 in 2023.
The recent downturn in 2024–2025 followed the same script. While many tokens saw short-lived pumps, INJ slipped to $2.74 in October, forming another pronounced bottom. Weeks later, the market began shifting, and INJ returned to the $6 range, echoing the same early-cycle strength seen after previous lows.
Technical Structure Points Toward Continued Recovery
Across every cycle, Injective has historically consolidated for five to six months before mounting a sustained move. That same accumulation structure appears to be forming again as price stabilizes and sentiment steadily improves.
Traders watching the injective INJ price prediction for 2025 often point to early 2026 as the window where momentum tends to accelerate. Some analysts even expect a new all-time high by 2027—not guaranteed, but consistent with how the asset has behaved after long periods of stagnation.
Developer Growth Signals Underlying Strength
Injective’s fundamentals are also gaining traction. Over the past year, the network ranked second among all Layer-1s in code commits, signaling a committed developer base and sustained innovation.
The project’s transition to its EVM mainnet in November only reinforces that progress. This upgrade expands its capabilities and improves reliability, giving the recovery narrative more weight as the ecosystem continues to mature.
Also Read: Canary Capital Files First Staked Injective (INJ) ETF With SEC, Fueling 5% Price Surge
Injective’s market recovery is still early, but its recurring October bottom pattern, strong developer activity, and new mainnet launch suggest a healthier cycle may be forming. If history rhymes, INJ could be positioning itself for another significant move in 2025 and beyond.
Disclaimer: The information in this article is for general purposes only and does not constitute financial advice. The author’s views are personal and may not reflect the views of Chain Affairs. Before making any investment decisions, you should always conduct your own research. Chain Affairs is not responsible for any financial losses.
I’m your translator between the financial Old World and the new frontier of crypto. After a career demystifying economics and markets, I enjoy elucidating crypto – from investment risks to earth-shaking potential. Let’s explore!
